James G. Kahn, MD, MPH

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
James G. Kahn, MD, MPH

Professor in Residence, Department of Epidemiology and Biostatistics, School of Medicine, UCSF

jgkahn@ucsf.edu

Phone: (415) 476-6642
Box 0936, UCSF
San Francisco, CA 94143-0936

UCSF Profiles | Philip R. Lee Institute for Health Policy Studies

Cancer Center Membership

Associate Member ยป Cancer, Immunity, and Microenvironment

Selected Publications

  1. Salazar J, Saxena V, Kahn JG, Roberts JP, Mehta N, Volk M, Lai JC. Cost-Effectiveness of Direct-Acting Anti-viral Treatment in Hepatitis C-infected Liver Transplant Candidates with Compensated Cirrhosis and Hepatocellular Carcinoma. Transplantation. 2016 Dec 06.
    View on PubMed
  2. Chang W, Chamie G, Mwai D, Clark TD, Thirumurthy H, Charlebois ED, Petersen M, Kabami J, Ssemmondo E, Kadede K, Kwarisiima D, Sang N, Bukusi EA, Cohen CR, Kamya M, Havlir DV, Kahn JG. Implementation and Operational Research: Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa. J Acquir Immune Defic Syndr. 2016 Nov 1; 73(3):e39-e45.
    View on PubMed
  3. Amanyire G, Semitala FC, Namusobya J, Katuramu R, Kampiire L, Wallenta J, Charlebois E, Camlin C, Kahn J, Chang W, Glidden D, Kamya M, Havlir D, Geng E. Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial. Lancet HIV. 2016 Aug 27.
    View on PubMed
  4. Goodell AJ, Kahn JG, Ndeki SS, Kaale E, Kaaya EE, Macfarlane SB. Modeling solutions to Tanzania's physician workforce challenge. Glob Health Action. 2016; 9:31597.
    View on PubMed
  5. Marseille E, Kahn JG. A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact. PLoS Med. 2016 May; 13(5):e1002031.
    View on PubMed
  6. Burgos JL, Patterson TL, Graff-Zivin JS, Kahn JG, Rangel MG, Lozada MR, Staines H, Strathdee SA. Cost-Effectiveness of Combined Sexual and Injection Risk Reduction Interventions among Female Sex Workers Who Inject Drugs in Two Very Distinct Mexican Border Cities. PLoS One. 2016; 11(2):e0147719.
    View on PubMed
  7. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan 1; 176(1):65-73.
    View on PubMed
  8. Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DV, Kahn JG. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda. PLoS One. 2015; 10(12):e0143433.
    View on PubMed
  9. Kwek SS, Kahn J, Greaney SK, Lewis J, Cha E, Zhang L, Weber RW, Leonard L, Markovic SN, Fong L, Spitler LE. GM-CSF and ipilimumab therapy in metastatic melanoma: Clinical outcomes and immunologic responses. Oncoimmunology. 2016 Apr; 5(4):e1101204.
    View on PubMed
  10. Curl PK, Kahn JG, Ordovas KG, Elicker BM, Naeger DM. Understanding Cost-Effectiveness Analyses: An Explanation Using Three Different Analyses of Lung Cancer Screening. AJR Am J Roentgenol. 2015 Aug; 205(2):344-7.
    View on PubMed
  11. Kahn JG, Hofmann P. Research ethics and health care reform. Science. 2015 Jun 19; 348(6241):1325-6.
    View on PubMed
  12. Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL. Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Glob Health Action. 2015; 8:27695.
    View on PubMed
  13. Juillard C, Smith R, Anaya N, Garcia A, Kahn JG, Dicker RA. Saving lives and saving money: hospital-based violence intervention is cost-effective. J Trauma Acute Care Surg. 2015 Feb; 78(2):252-7; discussion 257-8.
    View on PubMed
  14. Mirzazadeh A, Malekinejad M, Kahn JG. Relative risk reduction is useful metric to standardize effect size for public heath interventions for translational research. J Clin Epidemiol. 2015 Mar; 68(3):317-23.
    View on PubMed
  15. Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 1; 93(2):118-24.
    View on PubMed
  16. Jiwani A, Himmelstein D, Woolhandler S, Kahn JG. Billing and insurance-related administrative costs in United States' health care: synthesis of micro-costing evidence. BMC Health Serv Res. 2014; 14:556.
    View on PubMed
  17. Zygourakis CC, Kahn JG. Cost-effectiveness research in neurosurgery. Neurosurg Clin N Am. 2015 Apr; 26(2):189-96, viii.
    View on PubMed
  18. Zygourakis CC, Oh T, Sun MZ, Barani I, Kahn JG, Parsa AT. Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation. Neurosurg Focus. 2014 Nov; 37(5):E8.
    View on PubMed
  19. Curl P, Vujic I, van 't Veer LJ, Ortiz-Urda S, Kahn JG. Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. PLoS One. 2014; 9(9):e107255.
    View on PubMed
  20. Marseille E, Kahn JG. Avahan and the cost-effectiveness of "prevention as prevention". Lancet Glob Health. 2014 Sep; 2(9):e493-4.
    View on PubMed

Go to UCSF Profiles, powered by CTSI